An overview of the resilience world: Proceedings of the American Geriatrics Society and National Institute on Aging State of Resilience Science Conference.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
08 2023
Historique:
received: 04 04 2023
accepted: 04 04 2023
pmc-release: 01 08 2024
medline: 7 8 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: ppublish

Résumé

Resilience, which relates to one's ability to respond to stressors, typically declines with age and the development of comorbid conditions in older organisms. Although progress has been made to improve our understanding of resilience in older adults, disciplines have employed different frameworks and definitions to study various aspects of older adults' response to acute or chronic stressors. "Overview of the Resilience World: State of the Science," a bench-to-bedside conference on October 12-13, 2022, was sponsored by the American Geriatrics Society and National Institute on Aging. This conference, summarized in this report, explored commonalities and differences among the frameworks of resilience most commonly used in aging research in the three domains of resilience: physical, cognitive, and psychosocial. These three main domains are intertwined, and stressors in one domain can lead to effects in other domains. The themes of the conference sessions included underlying contributors to resilience, the dynamic nature of resilience throughout the life span, and the role of resilience in health equity. Although participants did not agree on a single definition of "resilience(s)," they identified common core elements of a definition that can be applied to all domains and noted unique features that are domain specific. The presentations and discussions led to recommendations for new longitudinal studies of the impact of exposures to stressors on resilience in older adults, the use of new and existing cohort study data, natural experiments (including the COVID-19 pandemic), and preclinical models for resilience research, as well as translational research to bring findings on resilience to patient care.

Identifiants

pubmed: 37079440
doi: 10.1111/jgs.18388
pmc: PMC10523918
mid: NIHMS1894957
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2381-2392

Subventions

Organisme : NIA NIH HHS
ID : R13 AG054139
Pays : United States

Informations de copyright

© 2023 The American Geriatrics Society.

Références

J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):e166-e172
pubmed: 32386291
J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):489-95
pubmed: 26718984
Child Dev. 2014 Jan-Feb;85(1):6-20
pubmed: 24341286
Compr Physiol. 2022 Apr 26;12(3):3575-3620
pubmed: 35578945
Geroscience. 2017 Feb;39(1):83-92
pubmed: 28299637
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):11883-11890
pubmed: 30373844
J Alzheimers Dis. 2018;64(s1):S161-S189
pubmed: 29865057
J Am Geriatr Soc. 2021 Nov;69(11):3232-3241
pubmed: 34325481
JAMA Netw Open. 2020 Jun 1;3(6):e207559
pubmed: 32525547
J Am Geriatr Soc. 2021 Jan;69(1):20-29
pubmed: 32965024
Perspect Psychol Sci. 2022 Nov;17(6):1591-1603
pubmed: 35748196
J Am Geriatr Soc. 2018 Aug;66(8):1455-1458
pubmed: 29727469
Neuropsychol Rev. 2008 Sep;18(3):255-68
pubmed: 18841477
Am Psychol. 2020 Oct;75(7):897-908
pubmed: 32567879
Brain. 2021 Aug 17;144(7):2166-2175
pubmed: 33742668
Neurobiol Aging. 2019 Nov;83:124-129
pubmed: 31732015
Neuroepidemiology. 2005;25(4):163-75
pubmed: 16103727
Alzheimers Dement. 2020 Sep;16(9):1305-1311
pubmed: 30222945
Clin Neuropsychol. 2010 Apr;24(3):429-53
pubmed: 20373222

Auteurs

Peter M Abadir (PM)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Karen Bandeen-Roche (K)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cindy Bergeman (C)

University of Notre Dame, Notre Dame, Indiana, USA.

David Bennett (D)

Rush University, Chicago, Illinois, USA.

Daniel Davis (D)

University College London, London, UK.

Amy Kind (A)

Center for Health Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Nathan LeBrasseur (N)

Mayo Clinic, Scottsdale, Arizona, USA.

Yaakov Stern (Y)

Columbia University, New York City, New York, USA.

Ravi Varadhan (R)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Heather E Whitson (HE)

Duke University, Durham, North Carolina, USA.
Durham VA Geriatrics Research, Education, and Clinical Center, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH